Fig. 2From: Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinomaT subsets in peripheral blood of PTC patients with N0 and Nx stage. a. The CD3+, CD4+, CD8+ and CD38+ expression detected by flow cytometry. b. CD8+HLA-DR+ expression on peripheral CD3+ T cells. c. CD4+HLA-DR+ expression on peripheral CD3+ T cells. d. CD8+CD38+ expression on peripheral CD3+ T cells. p < 0.05 represents a significant differenceBack to article page